tiprankstipranks
Seelos Therapeutics (SEEL)
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Technical Analysis

1,072 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Seelos Therapeutics’s (SEEL) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Seelos Therapeutics is a Sell.
Seelos Therapeutics’s (SEEL) 20-Day exponential moving average is 0.92, while Seelos Therapeutics’s (SEEL) share price is $0.995, making it a Sell.
Seelos Therapeutics’s (SEEL) 50-Day exponential moving average is 1.84, while Seelos Therapeutics’s (SEEL) share price is $0.995, making it a Sell.

Seelos Therapeutics (SEEL) Pivot Points

Feb 27, 2024, 02:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.70
0.73
0.76
0.79
0.83
0.86
0.89
Fibonacci
0.73
0.75
0.77
0.79
0.82
0.83
0.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seelos Therapeutics (SEEL) Moving Averages

Feb 27, 2024, 02:06 AM
Period
Simple
Exponential
MA5
0.82Buy
0.81Buy
MA10
0.81Buy
0.83Buy
MA20
0.88Sell
0.92Sell
MA50
1.22Sell
1.84Sell
MA100
2.87Sell
5.51Sell
MA200
17.64Sell
14.31Sell
Seelos Therapeutics’s (SEEL) 10-Day exponential moving average is 0.83, while Seelos Therapeutics’s (SEEL) share price is $0.995, making it a Buy.
Seelos Therapeutics’s (SEEL) 100-Day exponential moving average is 5.51, while Seelos Therapeutics’s (SEEL) share price is $0.995, making it a Sell.
Seelos Therapeutics’s (SEEL) stock price is $0.995 and Seelos Therapeutics’s (SEEL) 50-day simple moving average is 1.22, creating a Sell signal.
Seelos Therapeutics’s (SEEL) stock price is $0.995 and Seelos Therapeutics’s (SEEL) 100-day simple moving average is 2.87, creating a Sell signal.
Seelos Therapeutics’s (SEEL) stock price is $0.995 and Seelos Therapeutics’s (SEEL) 200-day simple moving average is 17.64, creating a Sell signal.

Seelos Therapeutics (SEEL) Technical Indicators

Feb 27, 2024, 02:06 AM
Name
Value
Implied Action
RSI (14)
35.58
Neutral
STOCH (9,6)
60.72
Neutral
STOCHRSI (14)
30.13
Neutral
MACD (12,26)
-0.16
Sell
ADX (14)
28.89
Neutral
Williams %R
-58.45
Buy
CCI (14)
-43.81
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
54.19
Neutral
ROC
-15.31
Sell
Seelos Therapeutics’s (SEEL) Relative Strength Index (RSI) is 35.58, creating a Neutral signal.
Seelos Therapeutics’s (SEEL) Trend Strength Indicator (ADX) is 28.89, creating a Neutral signal.
Seelos Therapeutics’s (SEEL) Commodity Channel Index (CCI) is -43.81, creating a Neutral signal.
Seelos Therapeutics’s (SEEL) Price Rate of Change (ROC) is -15.31, creating a Sell signal.

FAQ

Is SEEL a Buy, Hold, or Sell?
Based on SEEL’s technical indicators, SEEL is a Sell.
    What is SEEL’s RSI (14)?
    SEEL’s RSI (14) is 35.58, which suggests SEEL is a Neutral.
      What is SEEL’s MACD?
      SEEL’s MACD is -0.16, which suggests SEEL is a Sell.
        What is SEEL’s 5-day moving average?
        SEEL’s 5-day moving average is 0.82, which suggests SEEL is a Buy.
          What is SEEL’s 20-day moving average?
          SEEL 20-day moving average is 0.88, which suggests SEEL is a Sell.
            What is SEEL’s 50-day moving average?
            SEEL’s 50-day moving average is 1.22, which suggests SEEL is a Sell.
              What is SEEL’s 200-day moving average?
              SEEL’s 200-day moving average is 17.64, which suggests SEEL is a Sell.
                What is SEEL’s Williams % R (14)?
                SEEL’s Williams % R (14) is -58.45, which suggests SEEL is a Buy.
                  What is SEEL’s CCI (14)?
                  SEEL’s CCI (14) is -43.81, which suggests SEEL is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis